HST Global Inc. Current Ratio

Current Ratio of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Ratio growth rates and interactive chart. The current ratio is a liquidity ratio that measures whether a firm has enough resources to meet its short-term obligations. It is calculated as current assets divided by current liabilities. A ratio below 1 indicates potential trouble for a company, as it doesn't have enough current assets to pay for its short-term liabilities. A ratio above 2 is usually considered healthy.


Highlights and Quick Summary

  • Current Ratio for the quarter ending June 29, 2020 was 0.02 (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly Current Ratio increased by Infinity%
  • Annual Current Ratio for 2019 was 0.37 (a Infinity% increase from previous year)
  • Annual Current Ratio for 2018 was 0.0 (a -100.0% decrease from previous year)
  • Annual Current Ratio for 2017 was 0.0 (a -50.0% decrease from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Ratio of HST Global Inc.

Most recent Current Ratioof HSTC including historical data for past 10 years.

Interactive Chart of Current Ratio of HST Global Inc.

HST Global Inc. Current Ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.02 0.0
2019 0.37 0.0 0.0 0.0 0.37
2018 0.0 0.0 0.0 0.0 0.0
2017 0.0 0.0 0.0 0.0 0.0
2016 0.0 0.0 0.0 0.0 0.0
2015 0.0 0.0 0.0 0.0 0.0
2014 0.0 0.0 0.0 0.0 0.0
2013 0.0 0.0 0.0 0.0 0.0
2012 0.0 0.0 0.0 0.0 0.0
2011 0.0 0.0 0.0 0.0
2010 0.0 -0.01 -0.01 0.01 0.0
2009 0.0 0.0

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.